Table 1.
Factor | Total (N=309) |
---|---|
Age (at first visit), y, mean ± SD | 35.1 ± 20.3 |
Male, No. (%) | 118 (38.2%) |
White, No. (%) | 232 (75.1%) |
African American, No. (%) | 49 (15.9%) |
Family history of kidney disease, No. (%) | |
Yes | 163 (52.8%) |
No | 143 (46.3%) |
N/A | 3 (1.0%) |
Presentations, No. (%) | |
Glomerular disease | 102 (33.0%) |
Cystic kidney disease | 78 (25.2%) |
Electrolyte disorders | 77 (24.9%) |
Congenital anomalies of kidneys and urinary tract | 21 (6.8%) |
Kidney stones and or nephrocalcinosis | 10 (3.2%) |
Living donor | 9 (2.9%) |
Tubulointerstitial disease | 3 (1.0%) |
Renal vascular disease | 3 (1.0%) |
Family history only | 5 (1.6%) |
Insurance status, No. (%) | |
Private | 184 (59.5%) |
Medicare | 50 (16.2%) |
Medicaid | 64 (20.7%) |
International patient | 3 (1.0%) |
Military | 5 (1.60%) |
No insurance | 2 (0.60%) |
Kidney failure, No. (%) | 33 (10.7%) |
eGFRa, 60 mL/min/1.73 m2, mean ± SD | 88.7 ± 45.6 |
Abbreviations: eGFR, estimated glomerular filtration rate; N/A, not applicable; SD, standard deviation.
Data not available for all subjects. eGFR in pediatric patients is calculated from the Schwartz equation based on a stable serum creatinine and height.